| Date | Form | Description | Docs | XBRL | Pages |
| 09/07/16 | 3/A | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/01/16 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/01/16 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 08/26/16 | 8-K | Current report filing |
|
3 | |
| 08/26/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 07/05/16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 07/05/16 | DEF 14A | Definitive proxy statements |
|
46 | |
| 07/05/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/29/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces $5 Million Share Repurchase Program
Read More...